Roche Diabetes Care recalled its Accu-Chek Connect diabetes management app over software issues, according to an FDA safety alert issued Feb. 15.

Roche has secured a new FDA approval for its first companion diagnostic test aimed at identifying breast cancer patients with so-called “HER2-ultralow” status.

Stephen Ranjan believes teamwork is just as crucial as technology in building successful digital healthcare solutions in the pharma space ...

Switzerland's Roche will acquire its U.S. collaboration partner Poseida Therapeutics in a cash deal worth up to $1.5 billion, banking on complex immune cell therapies against several types of ...

Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer’s disease symptoms in high-risk people, its latest investment in one of the most failure-prone areas of ...

Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer’s disease symptoms in high-risk people, its latest investment in one of the most failure-prone areas of ...